Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kelley Yuan"'
Autor:
Kelsey Sokol, Kelley Yuan, Maria Piddoubny, Ellen Sweeney, Anne Delengowski, Katlin Fendler, Gloria Espinosa, Judith Alberto, Patricia Galanis, Carol Gung, Meghan Stokley, Mercy George, Mary Harris, Ubaldo Martinez-Outschoorn, Onder Alpdogan, Pierluigi Porcu, Adam F. Binder
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
IntroductionMethotrexate (MTX) a folate antagonist is often given in high doses (≥500 mg/m2) to treat a variety of disease processes. While inpatient administration has been the norm, outpatient administration, has been shown to be safe, effective,
Externí odkaz:
https://doaj.org/article/6757f7c738b94c7aa3e79f378ee28e54
Autor:
Hans E. Grossniklaus, Vanessa M. Morales-Tirado, Abigail Lepsch, Mercy W. Kibe, Matthew W. Wilson, Matthew W. McEwen, Qing Zhang, Kelley Yuan, Ryan P. Lee, Xiang Di Wang, Bradley T Gao, Neel Patel, Benjamin King, Hua Yang, Monica M. Jablonsk, Zachary K. Goldsmith, Sumana R Chintalapudi
Publikováno v:
The Ophthalmology – Open Journal. 3:21-30
Autor:
Matthew W. McEwen, Vanessa M. Morales-Tirado, Magaly Martinez-Ferrer, Andrew S. Irvine, Samuel R. Barsh, Rachel C. Brennan, Jacqueline Flores-Otero, Zachary K. Goldsmith, Madison K. Ritter, Matthew W. Wilson, Kelley Yuan, Aileen M. Garcia-Vargas, William Coppess
Publikováno v:
Investigative Ophthalmology & Visual Science
Purpose Vitreous seeding remains the primary reason for treatment failure in eyes with retinoblastoma (Rb). Systemic and intra-arterial chemotherapy, each with its own inherent set of complications, have improved salvage rates for eyes with advanced
Publikováno v:
Oncomedicine. 2:52-60
Autor:
Kelley Yuan
Publikováno v:
Academic medicine : journal of the Association of American Medical Colleges. 94(4)
Autor:
Mercy George, Adam Binder, Carol Gung, Katlin Fendler, Ubaldo E. Martinez-Outschoorn, Samantha Burdette, Anne Delengowski, Kelsey Sokol, Maria Piddoubny, Onder Alpdogan, Kelley Yuan, Patricia Galanis, Pierluigi Porcu
Publikováno v:
Journal of Clinical Oncology. 38:30-30
30 Background: High-dose methotrexate (HDMTX) is administered for the treatment of primary central nervous system (CNS) lymphoma (PCNSL), leptomeningeal metastases, and osteosarcoma, as well as CNS prophylaxis in patients with high-risk lymphoma and
Autor:
Kelley Yuan
Publikováno v:
Academic Medicine. 92:1695